Navigation Links
West Announces Third Quarter 2009 Results
Date:11/3/2009

savings in the range of $4.0 million annually.

During the third quarter of 2009, the Company recognized $3.9 million in pre-tax ($1.7 million after-tax) benefits as a result of relief from penalties, administrative charges and interest associated with certain tax deficiencies in Brazil that were recorded in 2007. The relief is pursuant to an amnesty program initiated by the Brazilian government. In addition, the Company recognized a $0.4 million reduction to tax expense in the quarter from the resolution of prior-year tax contingencies. During the third quarter of 2008, the Company reduced certain prior-year tax contingency reserves, recognizing income of $2.2 million in that quarter.

2008 third quarter results included $1.8 million of pre-tax charges for costs that were reimbursed under a contract settlement agreement with Nektar Therapeutics for converting the former Exubera® device production facility. The settlement had no impact on results in the current quarter.

Financial Guidance

The Company revised its 2009 guidance and previewed revenue expectations for 2010. The changes are intended to reflect management's current expectations and include revisions to revenue, gross profit and Adjusted Diluted EPS(1) estimates. Revised full-year 2009 financial guidance, at assumed exchange rates(3), is summarized as follows:

                                                              2009 Guidance
                                                              -------------
    Consolidated Sales(3)                            $1.03 to $1.05 billion
    Pharmaceutical Systems Revenue(3)                  $790 to $800 million
    Pharmaceutical Systems Gross Profit as a Percent
     of Sales                                                         33.4%
    Tech Group Revenue (includes $12 million of
     inter-company sales)(3)
    Tech Group Gross Profit as a Percent of Sales      $250 to $255 million
        
'/>"/>
SOURCE  West Pharmaceutical Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced today that the US Patent and Trademark Office has allowed its patent application o
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
(Date:12/3/2009)WARRENDALE, Pa., Dec. 3 Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Co
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Saving Lives Is a Growth Industry 55875 1Saving Lives Is a Growth Industry 55875 2Saving Lives Is a Growth Industry 55875 3China Kangtai Cactus Biotech to Launch Patented Cactus based Low Tar Low or Zero Nicotine Cigarettes 13772 1China Kangtai Cactus Biotech to Launch Patented Cactus based Low Tar Low or Zero Nicotine Cigarettes 13772 2China Kangtai Cactus Biotech to Launch Patented Cactus based Low Tar Low or Zero Nicotine Cigarettes 13772 3Studies in animals suggest 2009 H1N1 virus may have biological advantage over seasonal influenza 55873 1Studies in animals suggest 2009 H1N1 virus may have biological advantage over seasonal influenza 55873 2
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Dental tourism is a phenomenon that was started by people that were looking for an alternative to the high price of dental work in the US, Canada, and other countries. In their search for lower priced
Breaking Medicine News(10 mins):Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
...e smoking there is probably misuse of alcohol too,...esearchers in the Archives// of Internal Medicine.... used as a clinical indicator for alcohol misuse, ... although brief screening and brief intervention p...
...umer interests and those of the pharmaceutical ind... Senate Committee approved// a bill that would clo...cessary powers to require drug makers to wait two ...il to do post-approval studies and to ban advertis...
...he flu is nothing to be sneezed at//. The res...iversity of Texas-Houston, showed that about 90, 0...he U.S alone. The researchers say that this i... heart disease should never forgo their medication...
...h Haikerwal, said today that war veterans would ha...vices from 1 May following// the introduction of i... Officer (LMO) scheme for veterans’ health care. ... In practical terms, this means that patients ...
...ted that only a small percentage of food imported ...her, the 1.3% that is inspected// reveal contamina...he rest of the food that escapes inspection? ...to lenient food laws in the countries from where t...
...argest collections of liver tissue samples ever ac...System researchers have embarked on a massive stud... Nonalcoholic fatty liver disease starts with t...potentially fatal cirrhosis. If the damage becomes...
Other Medicine News:Health News:Smoking Indicator of Alcohol Misuse 2Health News:Moratorium Proposed on Advertisements of Newly Approved Drugs 2Health News:The Flu- More Than Just That 2Health News:Geisinger Launches Extensive Study on Obesity and Related Liver Problem 2
Insulin Autoantibody (IAA)
Benchtop Laminar Hood (Universal Hood)
Remote Blower With Bag-In/Bag-Out Option
Class II Type B2 Biological Safety Cabinet
Medicine Products: